相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans
Verity L. Chadwick et al.
CURRENT OPINION IN PSYCHIATRY (2020)
Activation of mineralocorticoid receptors facilitate the acquisition of fear memory extinction and impair the generalization of fear memory in diabetic animals
Thiago Oliari Ribeiro et al.
PSYCHOPHARMACOLOGY (2020)
Serious adverse effects of cannabidiol (CBD): a review of randomized controlled trials
Rafael G. Dos Santos et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2020)
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
Tommaso Cassano et al.
FRONTIERS IN PHARMACOLOGY (2020)
Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes
Yane Costa Chaves et al.
NEUROSCIENCE LETTERS (2020)
Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex
Amanda J. Sales et al.
MOLECULAR NEUROBIOLOGY (2019)
Hyperglycemia-Driven Neuroinflammation Compromises BBB Leading to Memory Loss in Both Diabetes Mellitus (DM) Type 1 and Type 2 Mouse Models
Slava Rom et al.
MOLECULAR NEUROBIOLOGY (2019)
Posttraumatic stress disorder-type behaviors in streptozotocin-induced diabetic rats can be prevented by prolonged treatment with vitamin E
Camila Pasquini de Souza et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
Danilo De Gregorio et al.
PAIN (2019)
Diabetic encephalopathy: beneficial effects of supplementation with fatty acids 3 and nordihydroguaiaretic acid in a spontaneous diabetes rat model
Gustavo Tomas Diaz-Gerevini et al.
LIPIDS IN HEALTH AND DISEASE (2019)
Anxiety disorders and medical illness comorbidity and treatment implications
Milan Latas et al.
CURRENT OPINION IN PSYCHIATRY (2019)
Role of Cannabinoid Receptor Type 1 in Insulin Resistance and Its Biological Implications
Arulkumar Nagappan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors
Carlos Henrique Alves Jesus et al.
BRAIN RESEARCH (2019)
Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
Gabriela Pandini Silote et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2019)
Rotenone protects against β-cell apoptosis and attenuates type 1 diabetes mellitus
Mengqiu Wu et al.
APOPTOSIS (2019)
Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications
Vivek S. Kumawat et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Antidiabetic treatment on memory and spatial learning: From the pancreas to the neuron
Eleni Xourgia et al.
WORLD JOURNAL OF DIABETES (2019)
Associations among comorbid anxiety, psychiatric symptomatology, and diabetic control in a population with serious mental illness and diabetes: Findings from an interventional randomized controlled trial
Awais Aftab et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2018)
Quantitative profiling of neurotransmitter abnormalities in brain, cerebrospinal fluid, and serum of experimental diabetic encephalopathy male rat
Xiaowen Han et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2018)
Effect of glucagon-like peptide-1 analogue; Exendin-4, on cognitive functions in type 2 diabetes mellitus; possible modulation of brain derived neurotrophic factor and brain Visfatin
O. M. Abdelwahed et al.
BRAIN RESEARCH BULLETIN (2018)
Investigating the longitudinal association between diabetes and anxiety: a systematic review and meta-analysis
K. J. Smith et al.
DIABETIC MEDICINE (2018)
Prevalence of mental disorders and related functioning and treatment engagement among people with diabetes
Matthew Tyler Boden
JOURNAL OF PSYCHOSOMATIC RESEARCH (2018)
The antioxidant gallic acid induces anxiolytic-, but not antidepressant-like effect, in streptozotocin-induced diabetes
Mariana Machado Pereira et al.
METABOLIC BRAIN DISEASE (2018)
The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
Manoela V. Fogaca et al.
NEUROPHARMACOLOGY (2018)
Sub-chronic treatment with cannabidiol but not with URB597 induced a mild antidepressant-like effect in diabetic rats
Helen de Morais et al.
NEUROSCIENCE LETTERS (2018)
Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels
Amanda J. Sales et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
The effects of safranal, a constitute of saffron, and metformin on spatial learning and memory impairments in type-1 diabetic rats: behavioral and hippocampal histopathological and biochemical evaluations
Fatemeh Delkhosh-Kasmaie et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
Jose A. Crippa et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Impact of Antidepressant Therapy on Glycemic Control in Canadian Primary Care Patients With Diabetes Mellitus
Justin Gagnon et al.
FRONTIERS IN NUTRITION (2018)
Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus
Joshua J. Joseph et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
Trajectories of depression in adults with newly diagnosed type 1 diabetes: results from the German Multicenter Diabetes Cohort Study
Hanna Kampling et al.
DIABETOLOGIA (2017)
Depression: a common and burdensome complication of diabetes that warrants the continued attention of clinicians, researchers and healthcare policy makers
Francois Pouwer
DIABETOLOGIA (2017)
The central cannabinoid receptor type-2 (CB2) and chronic pain
Yuchao Shang et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer
Mohamad Elbaz et al.
ONCOTARGET (2017)
Pathophysiological mechanisms involved in the relationship between diabetes and major depressive disorder
Gislaine Z. Reus et al.
LIFE SCIENCES (2017)
The endocannabinoid system as a target for novel anxiolytic drugs
Sachin Patel et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Telmisartan attenuates diabetes induced depression in rats
Urmila Aswar et al.
PHARMACOLOGICAL REPORTS (2017)
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
Debra A. Kendall et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
Alline C. Campos et al.
FRONTIERS IN PHARMACOLOGY (2017)
Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
Antonio W. Zuardi et al.
Frontiers in Pharmacology (2017)
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease
Subbiah Pugazhenthi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Brain cannabinoid receptor 2: expression, function and modulation
De-Jie Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Role of the endocannabinoid system in diabetes and diabetic complications
G. Gruden et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Reestablishment of the hyperglycemia to the normal levels seems not to be essential to the anxiolytic-like effect induced by insulin
Eder Gambeta et al.
METABOLIC BRAIN DISEASE (2016)
Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes
Isabella Caroline da Silva Dias et al.
MOLECULAR NEUROBIOLOGY (2016)
Effect of omega-3 polyunsaturated fatty acid treatment over mechanical allodynia and depressive-like behavior associated with experimental diabetes
Daiany D. B. Redivo et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors
A. G. Sartim et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice
Wilma Helena Oliveira et al.
BRAIN RESEARCH (2016)
The CB2 receptor and its role as a regulator of inflammation
Caroline Turcotte et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats
Rafeek Hidhayath Basha et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study
Khalid A. Jadoon et al.
DIABETES CARE (2016)
Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists
Mojgan Aghazadeh Tabrizi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors
Raquel Linge et al.
NEUROPHARMACOLOGY (2016)
Cannabidiol, neuroprotection and neuropsychiatric disorders
Alline C. Campos et al.
PHARMACOLOGICAL RESEARCH (2016)
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice
Angelica Pupin Schiavon et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
Gemma Navarro et al.
FRONTIERS IN NEUROSCIENCE (2016)
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Andrew H. Miller et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes
Christian Lehmann et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2016)
Prolonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction
Alonso Vilches-Flores et al.
BBA CLINICAL (2016)
Diabetes-associated depression: The serotonergic system as a novel multifunctional target
Visakh Prabhakar et al.
INDIAN JOURNAL OF PHARMACOLOGY (2015)
The endocannabinoid system in guarding against fear, anxiety and stress
Beat Lutz et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Depression and diabetes 2 The link between depression and diabetes: the search for shared mechanisms
Calum D. Moulton et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
β-Caryophyllene, a natural sesquiterpene, modulates carbohydrate metabolism in streptozotocin-induced diabetic rats
Rafeek Hidhayath Basha et al.
ACTA HISTOCHEMICA (2014)
Increased oxidative stress in prefrontal cortex and hippocampus is related to depressive-like behavior in streptozotocin-diabetic rats
Helen de Morais et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
A role for trans-caryophyllene in the moderation of insulin secretion
Wang Suijun et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa
Alexandre R. de Mello Schier et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Cannabinoid Receptor Type 2 Activation in Atherosclerosis and Acute Cardiovascular Diseases
Federico Carbone et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Interactions Between Diabetes and Anxiety and Depression Implications for Treatment
Alexander Bystritsky et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2014)
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
Orrin Devinsky et al.
EPILEPSIA (2014)
Ondansetron, a 5HT3 receptor antagonist reverses depression and anxiety-like behavior in streptozotocin-induced diabetic mice: Possible implication of serotonergic system
Deepali Gupta et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience
M. V. Fogaca et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Effect of Resveratrol on Behavioral Performance of Streptozotocin-induced Diabetic Mice in Anxiety Tests
Juan P. Damian et al.
EXPERIMENTAL ANIMALS (2014)
Diabetes and the Brain: Oxidative Stress, Inflammation, and Autophagy
Maria Muriach et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Psychiatric comorbidity in diabetes type 1: a cross-sectional observational study
Ana Claudia C. De Ornelas Maia et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2014)
Antidepressant use and new-onset diabetes: a systematic review and meta-analysis
Sandipan Bhattacharjee et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2013)
The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans
Richard L. Anderson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Cannabinoid CB1 receptor in the modulation of stress coping behavior in mice: The role of serotonin and different forebrain neuronal subpopulations
M. Haering et al.
NEUROPHARMACOLOGY (2013)
The impact of knowledge about diabetes, resilience and depression on glycemic control: a cross-sectional study among adolescents and young adults with type 1 diabetes
Fabio R. Munhoz Santos et al.
DIABETOLOGY & METABOLIC SYNDROME (2013)
The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications
Bela Horvath et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
E. M. Rock et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies
Sabine Steffens et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Epidemiology of depression and diabetes: A systematic review
Tapash Roy et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders
Alline Cristina Campos et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
F. M. Leweke et al.
TRANSLATIONAL PSYCHIATRY (2012)
Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala
Gislaine Z. Reus et al.
ACTA NEUROPSYCHIATRICA (2011)
Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans
C. Li et al.
DIABETES OBESITY & METABOLISM (2011)
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
George W. Booz
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Jose Alexandre S. Crippa et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Inflammation-associated depression: From serotonin to kynurenine
Robert Dantzer et al.
PSYCHONEUROENDOCRINOLOGY (2011)
The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors
Felipe V. Gomes et al.
PSYCHOPHARMACOLOGY (2011)
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
T. V. Zanelati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 beta-cells
Chen Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
Endocannabinoids in the Treatment of Mood Disorders: Evidence from Animal Models
Francis Rodriguez Bambico et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
Matthew N. Hill et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Angelo A. Izzo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
THE ENDOCANNABINOID SYSTEM AS A TARGET FOR NOVEL ANXIOLYTIC AND ANTIDEPRESSANT DRUGS
Silvana Gaetani et al.
ADVANCES IN NEUROPHARMACOLOGY (2009)
Mental disorders among persons with diabetes-Results from the World Mental Health Surveys
Elizabeth H. B. Lin et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2008)
Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats
Alline Cristina Campos et al.
PSYCHOPHARMACOLOGY (2008)
Role of cannabinoid CB2 receptors in glucose homeostasis in rats
Francisco Javier Bermudez-Silva et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Native rat hippocampal 5-HT1A receptors show constitutive activity
Jean-Claude Martel et al.
MOLECULAR PHARMACOLOGY (2007)
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice
L Weiss et al.
AUTOIMMUNITY (2006)
Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell
P Juan-Picó et al.
CELL CALCIUM (2006)
Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes
AB El-Remessy et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
G Gobbi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Agonistic properties of cannabidiol at 5-HT1a receptors
EB Russo et al.
NEUROCHEMICAL RESEARCH (2005)
Prevalence of anxiety in adults with diabetes - A systematic review
AB Grigsby et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2002)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
The prevalence of comorbid depression in adults with diabetes - A meta-analysis
RJ Anderson et al.
DIABETES CARE (2001)
分享论文
